August 7, 2018
View Full PaperGlobal prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients
Structured PICO
What is the global prevalence of resistant hypertension?
P
Population
3.2 million patients globally
O
Outcome
Prevalence of resistant hypertension
True-resistant hypertension has a high global prevalence, particularly in patients with chronic kidney disease, highlighting the critical need for ambulatory BP measurement to exclude pseudo-resistant hypertension.
Abstract
This study shows a high prevalence of true-resistant hypertension. This prevalence is lower than that of apparent treatment-resistant hypertension, demonstrating the importance to exclude causes of pseudo-resistant hypertension including white-coat hypertension with the use of ambulatory BP measurement. The burden of resistant hypertension is highest in patients with chronic kidney disease. New treatments for resistant hypertension are highly needed, considering the disastrous complications of the disease.